Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
ResMed Inc. has disclosed that company officer Brett Sandercock plans to sell 1,000 shares of common stock under Rule 144, with an approximate market value of $224,310, following the vesting of restricted stock awarded as compensation. The filing also shows Sandercock has sold 3,000 shares over the past three months through pre-arranged transactions, signaling ongoing insider share disposals but within the framework of a disclosed trading plan and without any asserted undisclosed adverse information about the company’s operations.
These planned and recent sales provide investors with visibility into insider trading activity, which may be interpreted as routine portfolio diversification rather than a signal of changing fundamentals. The notice confirms that the trades are being executed via Fidelity Brokerage Services LLC and references a Rule 10b5-1 trading plan adopted in February 2025, underscoring an intent to structure the transactions in compliance with U.S. securities regulations and to reduce the influence of non-public information on trading decisions.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$36.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. is a U.S.-based medical technology company specializing in devices and software for the treatment of sleep-disordered breathing and other respiratory conditions. Its primary products include sleep apnea machines, masks, and related cloud-connected solutions, serving patients, healthcare providers, and sleep clinics worldwide.
Average Trading Volume: 1,201,111
Technical Sentiment Signal: Hold
Current Market Cap: A$47.33B
For an in-depth examination of RMD stock, go to TipRanks’ Overview page.